DIVI'S LABORATORIES
Sector : Pharmaceuticals and health care | Largecap | BSE
Here's the live share price of Divi's Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
2.74₹ 156.25
As on Oct 3, 2025, 4:01 PM IST
Divi's Laboratories Price Performance
Today's LowToday's High
₹5,746.40₹5,873.40
₹5,866.95
52 Weeks' Low52 Weeks' High
₹4,941.70₹7,077.70
₹5,866.95
Open Price
₹5,788.45
Prev. Close
₹5,710.70
Volume
10,004
Over the last 5 years, the share price of Divi's Laboratories has gained 13.40% CAGR. Over the past year, the corresponding return has been 8.07%.
Divi's Laboratories’s current P/E of 67.54x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Divi's Laboratories Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Divi's Laboratories | -0.54 | -4.16 | -14.49 | 3.60 | 8.07 | 16.33 | 13.40 |
| Sun Pharmaceutical Industries | -0.03 | 4.02 | -3.00 | -5.06 | -14.95 | 19.89 | 25.48 |
| Cipla | 0.39 | -3.40 | 1.23 | 4.33 | -8.48 | 10.25 | 14.24 |
| Torrent Pharmaceuticals | -0.53 | -1.95 | 4.94 | 9.49 | 3.65 | 30.54 | 19.99 |
| Dr. Reddy's Laboratories | -2.10 | -0.74 | -1.87 | 8.55 | -7.35 | 12.18 | 3.88 |
| Mankind Pharma | -2.58 | -3.46 | 2.88 | 1.40 | -2.98 | 19.91 | 11.51 |
| Zydus Lifesciences | -2.96 | -0.75 | -0.68 | 10.94 | -7.49 | 34.18 | 19.01 |
| Lupin | 0.54 | 4.40 | 0.22 | -1.86 | -9.69 | 39.75 | 13.68 |
| Alkem Laboratories | -1.33 | 3.44 | 11.44 | 11.01 | -11.84 | 18.32 | 14.53 |
| Abbott India | -0.98 | -7.53 | -15.45 | 1.17 | 5.84 | 16.66 | 13.34 |
| Aurobindo Pharma | -0.30 | 7.07 | -5.54 | -5.61 | -24.98 | 26.89 | 5.33 |
| Glenmark Pharmaceuticals | -2.62 | 3.08 | 11.74 | 30.44 | 20.22 | 70.23 | 31.83 |
| Biocon | -1.05 | -1.15 | -4.42 | 2.88 | -1.36 | 6.44 | -5.15 |
| Laurus Labs | -3.29 | 0.75 | 14.37 | 42.39 | 88.22 | 19.14 | 24.01 |
| GlaxoSmithKline Pharmaceuticals | 0.58 | -0.02 | -16.66 | -1.01 | 0.47 | 24.76 | 11.88 |
| Anthem Biosciences | -5.58 | -5.61 | 3.96 | 3.96 | 3.96 | 1.30 | 0.78 |
| Cohance Lifesciences | -2.75 | -3.69 | -9.47 | -19.92 | -26.59 | 25.52 | 17.56 |
| Ipca Laboratories | -2.74 | -4.03 | -4.39 | -7.23 | -10.74 | 11.99 | 4.10 |
| Gland Pharma | -0.36 | 5.38 | 5.31 | 28.00 | 10.08 | -2.71 | 1.54 |
| Ajanta Pharma | -3.30 | -3.05 | -5.72 | -8.21 | -28.22 | 23.12 | 17.62 |
Over the last one year, Divi's Laboratories has gained 8.07% compared to peers like Sun Pharmaceutical Industries (-14.95%), Cipla (-8.48%), Torrent Pharmaceuticals (3.65%). From a 5 year perspective, Divi's Laboratories has outperformed peers relative to Sun Pharmaceutical Industries (25.48%) and Cipla (14.24%).
Divi's Laboratories Financials
Divi's Laboratories Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 6,098.91 | 5,758.97 |
| 10 | 6,071.15 | 5,849.01 |
| 20 | 6,084.91 | 5,948.34 |
| 50 | 6,272.39 | 6,122.06 |
| 100 | 6,415.88 | 6,191.16 |
| 200 | 6,117.93 | 6,030.19 |
Divi's Laboratories Share Holding Pattern
In the latest quarter, Divi's Laboratories remained same as its previous close in promoter holding, while DII stake decreased to 19.05%, FII holding rose to 19.74%, and public shareholding moved down to 9.32% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Divi's Laboratories Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| SBI Equity Hybrid Fund | 37,00,000 | 2.94 | 2,268.66 |
| SBI Blue Chip Fund | 27,31,710 | 3.2 | 1,674.95 |
| SBI Focused Equity Fund | 17,70,000 | 2.87 | 1,085.28 |
| Axis ELSS Tax Saver Fund | 10,75,888 | 1.91 | 659.68 |
| Nippon India Pharma Fund | 10,00,031 | 7.34 | 613.17 |
| Axis Focused Fund | 9,83,954 | 4.91 | 603.31 |
| ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund | 9,27,926 | 9.23 | 568.96 |
| SBI Multicap Fund | 9,20,000 | 2.52 | 564.1 |
| HDFC Balanced Advantage Fund - Regular Plan | 8,88,857 | 0.54 | 545 |
| Axis Bluechip Fund | 8,69,693 | 1.62 | 533.25 |
Divi's Laboratories Futures
| Price | (%) As on Invalid Date IST |
| Open Interest | (%) |
| High | |
| Low | |
| Open | |
| Close | |
| Contract Traded | |
| Turnover (in lakhs) |
Divi's Laboratories Options
Divi's Laboratories Corporate Actions
Date Time | Announcement |
|---|---|
| Sep 05, 2025, 7:55 PM IST | Divi's Lab - Announcement under Regulation 30 (LODR)-Change in Management |
| Aug 12, 2025, 2:49 PM IST | Divi's Lab - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
| Aug 11, 2025, 10:53 PM IST | Divi's Lab - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
| Aug 11, 2025, 10:46 PM IST | Divi's Lab - Shareholder Meeting / Postal Ballot-Outcome of AGM |
| Aug 06, 2025, 10:32 PM IST | Divi's Lab - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
About Divi's Laboratories
Divi's Laboratories Ltd. is a Public Limited Listed company incorporated on 12/10/1990 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24110TG1990PLC011854 and registration number is 011854. Currently Company is involved in the business activities of Manufacture of other pharmaceutical and botanical products like hina powder etc.. Company's Total Operating Revenue is Rs. 9198.00 Cr. and Equity Capital is Rs. 53.00 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressDivi Towers, 1-72/23(P)/DIVIS/303, Hyderabad Telangana 500032
- Contact
Management
- Dr. Ramesh B V NimmagaddaNon Exe.Chairman&Ind.Director
- Dr. Murali K DiviManaging Director
- Dr. Kiran S DiviWholeTime Director & CEO
- Ms. Nilima Prasad DiviWhole Time Director
- Dr. S Devendra RaoWhole Time Director
- Mr. N V RamanaExecutive Director
- Mr. K V ChowdaryIndependent Director
- Prof. S GanapatyIndependent Director
- Prof. Sunaina SinghIndependent Director
- Dr. Rajendra Kumar PremchandIndependent Director
FAQs on Divi's Laboratories Share Price
What is the share price of Divi's Laboratories?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Divi's Laboratories is ₹5,866.95 as on Oct 03, 2025.
What kind of stock is Divi's Laboratories?
The Divi's Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
What is the Market Cap of Divi's Laboratories?
The market cap of Divi's Laboratories is ₹155,749.09 Cr as on Oct 03, 2025.
What are today's High and Low prices of Divi's Laboratories?
Today’s highest and lowest price of Divi's Laboratories are ₹5,873.40 and ₹5,746.40.
What are the 52 Week High and 52 Week Low of Divi's Laboratories?
The 52-week high/low is the highest and lowest price at which Divi's Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Divi's Laboratories is ₹7,077.70 and 52-week low of Divi's Laboratories is ₹4,941.70 as on Oct 03, 2025.
How has the Divi's Laboratories performed historically in terms of returns?
The Divi's Laboratories has shown returns of 2.74% over the past day, -4.16% for the past month, -14.49% over 3 months, 8.07% over 1 year, 16.33% across 3 years, and 13.4% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Divi's Laboratories?
P/E ratio of and PB ratio of Divi's Laboratories are 67.54 and 11.35 on Oct 03, 2025. While the company gives a dividend yield of 0.51 per annum.
Trending In Market
Mutual Funds Screener
Stock Screener
Mutual Funds
IPO’s Open and Upcoming
Top Indices Performance
Stock Market Stats
Gold Rate Today
NSE Top Gainers
NSE Top Losers
BSE Top Gainers
BSE Top Losers
NSE 52-Week High
NSE 52-Week Low
BSE 52-Week High
BSE 52-Week Low
NSE Price Shocker
NSE Volume Shocker
BSE Price Shocker
BSE Volume Shocker
NSE Buyers
NSE Sellers
BSE Buyers
BSE Sellers
Silver Rate Today
Petrol Rate Today
Diesel Rate Today
✕
Market Data